Buy & Sell T-Rex 2X Inverse MSTR Daily Target ETF (MSTZ) – T-Rex 2X Inverse MSTR Daily Target ETF Price Today
Aura AI Summary
Key Stats
- -Market Cap
- Leveraged / InverseSector
- -71.31%3M Drawdown
- -Enterprise Value
- -Dividend Yield
- 86% Buy | 14% SellTrading Activity
- 2 daysTypical Hold Time
Over the past 52 weeks, T-Rex 2X Inverse MSTR Daily Target ETF has traded between a low of $3.12 and a high of $27.92, highlighting its annual price range. Over the past three months, T-Rex 2X Inverse MSTR Daily Target ETF has recorded a drawdown of -71.31%, reflecting recent price volatility. On average, investors hold T-Rex 2X Inverse MSTR Daily Target ETF for approximately 2 days, indicating typical investor behavior on the platform.
About T-Rex 2X Inverse MSTR Daily Target ETF
MSTZ is a leveraged ETF that seeks daily investment results corresponding to 200% of the inverse (opposite) of the daily performance of the MicroStrategy Incorporated (MSTR) stock. It is designed as a tactical tool for experienced traders to take a bearish position on MSTR, a company known for its large Bitcoin holdings. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment, as its performance over longer periods may significantly deviate from its stated daily objective.
Most Recent News
Block's AI-driven layoffs boost profits and EPS, setting a trend for tech firms to follow.
Block cut its workforce by over 4,000 in early 2026, yet posted a 51.8% growth in Q1 adjusted EPS and raised its full-year guidance by 62%. CEO Jack Dorsey credits AI tools, used by all employees, for enabling a smaller team to increase productivity ...

Kirby McInerney LLP investigates Qiagen over possible securities law violations after sales drop.
Kirby McInerney LLP is investigating Qiagen N.V. for potential violations of federal securities laws following the company's disclosure of a sales decline. Qiagen had previously forecasted 6-7% growth for its QuantiFERON product in 2026, but later re...

Alphatec faces investigation after missing revenue targets and share price drops 32%.
Alphatec Holdings reported lower-than-expected Q1 2026 revenue, primarily due to underperformance in its EOS imaging platform sales. The company reduced its full-year EOS revenue forecast from $85 million to $77 million, citing installation delays an...
